Kovitz Investment Group Partners, LLC Aerovate Therapeutics, Inc. Transaction History
Kovitz Investment Group Partners, LLC
- $21.5 Billion
- Q2 2025
A detailed history of Kovitz Investment Group Partners, LLC transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 24,210 shares of AVTE stock, worth $64,882. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,210
Previous 26,514
8.69%
Holding current value
$64,882
Previous $66,000
3.03%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AVTE
# of Institutions
12Shares Held
4.48MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY983KShares$2.63 Million0.0% of portfolio
-
Morgan Stanley New York, NY699KShares$1.87 Million0.0% of portfolio
-
Oup Management Co., LLC604KShares$1.62 Million18.43% of portfolio
-
Jpmorgan Chase & CO New York, NY75.7KShares$202,8060.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL40KShares$107,3250.0% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $65.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...